Health Care • Medical/Dental Instruments
$2.38 ▲ +0.12
(+5.31%)
MKT CAP: $181.3M • VOL: 832.3K
52W L $1 52W H $3
STIM // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $149.2M | $74.9M | $71.3M |
| YoY Revenue Growth % | +99.2% | +5.0% | — |
| Gross Profit | $72.3M | $54.2M | — |
| Gross Margin % | 48.5% | 72.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$31.4M | -$34.6M | -$30.6M |
| Operating Margin % | -21.1% | -46.2% | -42.8% |
| Net Income (GAAP) | -$39.0M | -$43.7M | -$30.2M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$20.4M | -$31.0M | -$32.0M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | -$20.4M | -$31.0M | -$32.0M |
| FCF Margin % | -13.7% | -41.4% | -44.9% |
| Return on Invested Capital (ROIC %) | -41.4% | -42.4% | — |
| Cash & Short-Term Equivalents | $28.1M | $18.5M | — |
| Total Debt (Short + Long Term) | $65.8M | $55.2M | — |
| Total Stockholders' Equity | $22.4M | $27.7M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR STIM.